Search NLS News

InDex Pharmaceuticals has entered into a conditional agreement to acquire all shares in Flerie Invest AB. Flerie will become a wholly-owned subsidiary of InDex Pharmaceuticals and Flerie’s shareholders will initially hold approximately 91.9% of the total number of shares and votes in the company, prior to the completion of the capital raise. As a result […]

Driving Innovation and Empowerment to Improve Women’s Health – that was the headline for a seminar held by Hologic and Medicon Valley Alliance on the 18th of April. The event took place in Copenhagen and was attended by prominent speakers from Denmark, Finland, Norway, and Sweden. In their welcoming addresses, Katrine Brems Olsen of Medicon […]

The planned facility will be AstraZeneca’s first end-to-end antibody drug conjugates (ADC) production site, fully incorporating all steps of the manufacturing process at a commercial scale. “Singapore is one of the world’s most attractive countries for investment given its reputation for excellence in complex manufacturing, and I am excited for AstraZeneca to locate our USD […]

The initiative will provide funding to maintain high-quality health databases in the country and to support research that uses this data to advance understanding of cardiometabolic diseases (CMD). The aim is to ensure that valuable data remains both secure and accessible for future research, strengthening the CMD research environment in Denmark, states Novo Nordisk Foundation […]

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Ulrika Hammarström, CEO and Founder of Scandinavian CRO (SCRO) was recently awarded Entrepreneur of the Year in Uppsala, and NLS asked her about building successful teams, her leadership style and women in life sciences. This prize is awarded by jury to an entrepreneur who has performed above and beyond and whose company has demonstrated long-term […]

Petri Rummukainen is a scientist at 3PBIOVIAN, a company formed through the recent combination of Biovian and 3P Biopharmaceuticals. He is responsible for planning, reporting, developing, and executing bioprocesses in collaboration with a team of scientists and engineers. He explains his role in the company and what he is thrilled about. Two years ago, Petri […]

Together with Bpifrance, Trill Impact Ventures has co-led a USD 25 million series B financing round in May Health, a French-American medical device company targeting Polycystic Ovary Syndrome (PCOS) related infertility. The round also saw participation from existing May Health investor Sofinnova Partners. Proceeds will advance the clinical development of May Health’s innovative device, as […]

The company has announced an expansion of its pipeline through the nomination of PKCtheta as the target of a new immunology project. The PKCtheta kinase plays a critical role in T-cell receptor signaling and is believed to be centrally involved in the pathogenesis of T-cell mediated inflammatory and autoimmune diseases e.g. ulcerative colitis and rheumatoid […]

Maria Alfaiate will join Lundbeck on 1 August 2024 and will be part of the Executive Management team. Maria Alfaiate will be responsible for strengthening corporate strategic functions and enhancing global marketing efforts. Her focus will be on optimizing Lundbeck’s ability to capitalize on both present and future opportunities. She brings significant experience from the […]